These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18219157)

  • 1. Importance of lipid levels in elderly diabetic individuals: baseline characteristics and 1-year survey of cardiovascular events.
    Hayashi T; Kawashima S; Itoh H; Yamada N; Sone H; Watanabe H; Hattori Y; Ohrui T; Yoshizumi M; Yokote K; Kubota K; Nomura H; Umegaki H; Iguchi A;
    Circ J; 2008 Feb; 72(2):218-25. PubMed ID: 18219157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age.
    Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ina K; Nomura H;
    Cardiovasc Diabetol; 2013 Jan; 12():10. PubMed ID: 23302697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic dyslipidemia and pathogenesis of ischemic heart disease].
    Sokolov EI; Perova NV
    Kardiologiia; 2003; 43(5):16-20. PubMed ID: 12891233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Macrovascular diseases-based on the data of Japanese cohort study (JCDM) including 1,016 very elderly diabetic individuals older than 75 years old].
    Hayashi T
    Nihon Rinsho; 2013 Nov; 71(11):1999-2004. PubMed ID: 24397173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alcohol consumption, S-LDL-cholesterol and risk of ischemic heart disease. 6-year follow-up in The Copenhagen Male Study].
    Hein HO; Suadicani P; Gyntelberg F
    Ugeskr Laeger; 1997 Jun; 159(26):4110-6. PubMed ID: 9229869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients.
    Hayashi T; Kawashima S; Nomura H; Itoh H; Watanabe H; Ohrui T; Yokote K; Sone H; Hattori Y; Yoshizumi M; Ina K; Kubota K;
    Cardiovasc Diabetol; 2011 Oct; 10():86. PubMed ID: 21978180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
    Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
    Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT).
    Koizumi J; Shimizu M; Miyamoto S; Origasa H; Mabuchi H
    J Atheroscler Thromb; 2002; 9(5):251-9. PubMed ID: 12409635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.
    Lamarche B; Tchernof A; Mauriège P; Cantin B; Dagenais GR; Lupien PJ; Després JP
    JAMA; 1998 Jun; 279(24):1955-61. PubMed ID: 9643858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
    Horiuchi H; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
    J Am Geriatr Soc; 2004 Dec; 52(12):1981-7. PubMed ID: 15571531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study.
    Jeppesen J; Hein HO; Suadicani P; Gyntelberg F
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1114-20. PubMed ID: 9194762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor lipid control in type-2 diabetics with and without ischemic heart disease.
    Akbar DH; Al-Gamdi AA; Hejazi NA
    Endocrine; 2003 Aug; 21(3):217-20. PubMed ID: 14515004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study.
    Howard BV; Robbins DC; Sievers ML; Lee ET; Rhoades D; Devereux RB; Cowan LD; Gray RS; Welty TK; Go OT; Howard WJ
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):830-5. PubMed ID: 10712410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study.
    St-Pierre AC; Cantin B; Dagenais GR; Mauriège P; Bernard PM; Després JP; Lamarche B
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):553-9. PubMed ID: 15618542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.
    Hayashi T; Kubota K; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Araki A; Noda M; Noto H; Sakuma I; Yoshizumi M; Ina K; Nomura H;
    Int J Cardiol; 2014 Dec; 177(3):860-6. PubMed ID: 25466567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.